They analyzed risk factors for mortality in 1379 KTRs in the 28 days following a COVID-19 diagnosis and found that one risk factor for increased mortality was the use of MMF or azathioprine, while the use of mammalian target of rapamycin (mTOR) inhibitors was associated with a decreased risk of death [13]. Here, MTOR is linked to COVID-19.